Table of contents
Volume 95, Issue 5
Published online 30 August 2006 (555-660)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Corrigendum
Minireview
Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation FREE
A S Turnell and J S Mymryk
Br J Cancer 95: 555-560; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603304
Clinical Studies
Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy FREE
S Sakano, T Wada, H Matsumoto, S Sugiyama, R Inoue, S Eguchi, H Ito, C Ohmi, H Matsuyama and K Naito
Br J Cancer 95: 561-570; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603290
A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours FREE
S Lowis, I Lewis, A Elsworth, C Weston, F Doz, G Vassal, R Bellott, J Robert, F Pein, S Ablett, R Pinkerton and D Frappaz On behalf of the United Kingdom Children's Cancer Study Group (UKCCSG) New Agents and Société Française d'Oncologie Pédiatrique (SFOP) Pharmacology Group
Br J Cancer 95: 571-580; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603288
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis FREE
T Eisen, T Ahmad, K T Flaherty, M Gore, S Kaye, R Marais, I Gibbens, S Hackett, M James, L M Schuchter, K L Nathanson, C Xia, R Simantov, B Schwartz, M Poulin-Costello, P J O'Dwyer and M J Ratain
Br J Cancer 95: 581-586; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603291
A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer FREE
G P Stathopoulos, K Syrigos, G Aravantinos, A Polyzos, P Papakotoulas, G Fountzilas, A Potamianou, N Ziras, J Boukovinas, J Varthalitis, N Androulakis, A Kotsakis, G Samonis and V Georgoulias
Br J Cancer 95: 587-592; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603301
How is place of death from cancer changing and what affects it? Analysis of cancer registration and service data FREE
E Davies, K M Linklater, R H Jack, L Clark and H Møller
Br J Cancer 95: 593-600; advance online publication, August 15, 2006; doi:10.1038/sj.bjc.6603305
Translational Therapeutics
NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel FREE
T Negishi, F Koizumi, H Uchino, J Kuroda, T Kawaguchi, S Naito and Y Matsumura
Br J Cancer 95: 601-606; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603311
Molecular Diagnostics
Evaluations of biomarkers associated with 5-FU sensitivity for non-small-cell lung cancer patients postoperatively treated with UFT FREE
J Nakano, C Huang, D Liu, D Masuya, T Nakashima, H Yokomise, M Ueno, H Wada and M Fukushima
Br J Cancer 95: 607-615; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603297
Expression of oestrogen receptor-
in oestrogen receptor-
negative human breast tumours FREE
G P Skliris, E Leygue, L Curtis-Snell, P H Watson and L C Murphy
Br J Cancer 95: 616-626; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603295
Factors influencing p53 expression in ovarian cancer as a biomarker of clinical outcome in multicentre studies FREE
P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul, K A Oien, K A ten Hoor, S de Jong, H Hollema, J M S Bartlett, R Brown and A G J van der Zee
Br J Cancer 95: 627-633; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603300
Expression of Osteopontin in oesophageal squamous cell carcinoma FREE
Y Kita, S Natsugoe, H Okumura, M Matsumoto, Y Uchikado, T Setoyama, T Owaki, S Ishigami and T Aikou
Br J Cancer 95: 634-638; advance online publication, August 1, 2006; doi:10.1038/sj.bjc.6603296
Epidemiology
CagA-producing Helicobacter pylori and increased risk of gastric cancer: a nested case–control study in Korea FREE
J Gwack, A Shin, C-S Kim, K-P Ko, Y Kim, J K Jun, J Bae, S K Park, Y-C Hong, D Kang, S-H Chang, H-R Shin and K-Y Yoo
Br J Cancer 95: 639-641; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603309
Risk of breast, ovary, and uterine corpus cancers among 85 268 women with AIDS FREE
J J Goedert, C Schairer, T S McNeel, N A Hessol, C S Rabkin and E A Engels for the HIV/AIDS Cancer Match Study
Br J Cancer 95: 642-648; advance online publication, July 25, 2006; doi:10.1038/sj.bjc.6603282
Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data FREE
D R Camidge, D L Stockton and M Bain
Br J Cancer 95: 649-652; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603293
The relation between socioeconomic and demographic factors and tumour stage in women diagnosed with breast cancer in Denmark, 1983–1999 FREE
S O Dalton, M Düring, L Ross, K Carlsen, P B Mortensen, J Lynch and C Johansen
Br J Cancer 95: 653-659; advance online publication, August 8, 2006; doi:10.1038/sj.bjc.6603294
Corrigendum
Excess cases of prostate cancer and estimated overdiagnosis associated with PSA testing in East Anglia FREE
N Pashayan, J Powles, C Brown and S W Duffy
Br J Cancer 95: 660; doi:10.1038/sj.bjc.6603330
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
